WENTWORTH KORY JAMES

CIK 00017256632 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001725663

Recent Transactions

50 trades

Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2025-11-21$9.98/sh−8,910→ 110,026 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2025-09-02$5.43/sh−1,734→ 118,936 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2025-04-03−11,134→ 20,023 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Common Stock
2025-04-03$2.10/sh+11,134→ 120,670 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2025-03-17$10.67/sh−1,784→ 109,536 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2025-03-03$11.68/sh−4,929→ 111,320 total
Award
Entrada Therapeutics, Inc.$TRDA
Common Stock
2025-03-01+42,400→ 116,249 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2025-03-01+63,300→ 63,300 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-12-02$2.10/sh+5,000→ 78,849 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-12-02$20.00/sh−5,000→ 73,849 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2024-12-02−5,000→ 31,157 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2024-11-29−1,000→ 36,157 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-11-29$2.10/sh+1,000→ 74,849 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-11-29$19.97/sh−1,000→ 73,849 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-11-11$19.98/sh−8,637→ 73,849 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2024-11-11−6,000→ 37,157 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-11-11$2.10/sh+6,000→ 82,486 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-09-09$14.97/sh−3,195→ 76,486 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-09-05$15.13/sh−165→ 79,681 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-09-04$15.42/sh−941→ 79,846 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-09-03$17.70/sh−14→ 80,787 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-09-03$15.76/sh−462→ 80,950 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-09-03$16.93/sh−149→ 80,801 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-07-08$14.95/sh−1,758→ 81,412 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-03-15$2.10/sh+9,000→ 83,170 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2024-03-15−9,000→ 43,157 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-03-06$12.31/sh−4,086→ 74,170 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-03-05$12.28/sh−1,471→ 78,256 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-03-04$12.42/sh−339→ 80,132 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-03-04$13.37/sh−405→ 79,727 total
Award
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-03-01+30,900→ 80,471 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2024-03-01+46,800→ 46,800 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-12-26$2.10/sh+94→ 49,665 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2023-12-26−94→ 52,157 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-12-26$16.67/sh−94→ 49,571 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-12-22$2.10/sh+10,206→ 59,777 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-12-22$15.24/sh−6,529→ 53,248 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-12-22$16.48/sh−3,677→ 49,571 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2023-12-22−10,206→ 52,251 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2023-12-21−2,200→ 62,457 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-12-21$2.10/sh+2,200→ 51,771 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-12-21$15.07/sh−2,200→ 49,571 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-09-06$13.45/sh−904→ 49,617 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-09-06$14.03/sh−46→ 49,571 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-09-05$14.46/sh−426→ 50,521 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2023-09-01+21,500→ 21,500 total
Award
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-09-01+14,200→ 50,947 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2023-07-11−3,884→ 64,657 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-07-11$18.00/sh−3,884→ 36,747 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-07-11$2.10/sh+3,884→ 40,631 total

Companies

Recent Filings

Address

C/O ENTRADA THERAPEUTICS, INC. ONE DESIGN CENTER PLACE, SUITE 17-500

BOSTON, MA, 02210

View on SEC.gov